Not Yet RecruitingNot Applicable

Fall Risk Assessment in Parkinson's Disease Using Kinetikos Health

Taiwan100 participantsStarted 2025-12-01

Plain-language summary

This is a single-center, prospective observational study aiming to validate the Kinetikos Health App for fall risk assessment in PD patients undergoing dopaminergic medication adjustments.

Who can participate

Age range20 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Age ≥20;
✓. PD diagnosis (MDS criteria);
✓. On levodopa monotherapy with motor fluctuations;
✓. Planned to start opicapone or safinamide;
✓. Consent provided.

Exclusion criteria

✕. Atypical/secondary parkinsonism;
✕. Moderate-severe dementia;
✕. DBS/MRgFUS/neurosurgery within 6 months;
✕. Severe comorbidities limiting test

What they're measuring

Change in fall-risk index (Kinetikos Health App Sit-to-Stand)

Timeframe: From baseline to 3 months

Trial details

NCT IDNCT07257393

SponsorTaipei Medical University Shuang Ho Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-06-30

Contact for this trial

Chen-Chih Chung, MD

+886-2-22490088 10670@s.tmu.edu.tw

View on ClinicalTrials.gov More Idiopathic Parkinsonism trials